{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-23-000297","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2023-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.573977+00:00","generated_at":"2026-06-18T12:53:27.428921+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lexaria's DehydraTECH-CBD diabetes study shows weight loss, improved triglycerides and cholesterol in obese rats","bullets":["7% body weight loss maintained over 8 weeks in obese diabetic Zucker rats dosed with DehydraTECH-CBD.","Triglyceride levels over 25% lower at 30 mg/Kg dose vs untreated obese rats (p=0.007).","Lower dose (30 mg/Kg) improved HDL cholesterol without significant effect on LDL; higher dose increased both.","Lower dose significantly improved locomotor activity (p<0.05) compared to untreated obese controls.","Study DIAB-A22-1 conducted by third-party lab in Canada over 8 weeks; no serious health concerns observed."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-23-000297","json":"https://secwatch.observer/filing/0001640334-23-000297.json","markdown":"https://secwatch.observer/filing/0001640334-23-000297.md","text":"https://secwatch.observer/filing/0001640334-23-000297.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033423000297/0001640334-23-000297-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033423000297/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T12:53:27.428921+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}